Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Pediatr Neurol. 2021 Mar 5;119:3–10. doi: 10.1016/j.pediatrneurol.2021.02.006

TABLE 1.

Demographics and Medications Used in N = 268 Respondents With Seizures

Population or SWS Demographic Respondents With History of Seizures (N = 268)
Sex
 Female 148 (55.2%)
 Male 120 (44.8%)
Adult versus child
 Child 231 (86.2%)
 Adult 37 (13.8%)
Ethnicity
 Hispanic/Latino origin 27 (10.1%)
 Not Hispanic/Latino origin 227 (84.7%)
 Unknown 14 (5.2%)
Race
 American Indian/Alaskan Native 1 (0.4%)
 Asian 17 (6.3%)
 Black 17 (6.3%)
 Native Hawaiian Pacific Islander 1 (0.4%)
 White 210 (78.4%)
 Multiracial 13 (4.9%)
 Unknown 9 (3.4%)
Brain involvement
 Unilateral 216 (80.6%)
 Bilateral 52 (19.4%)
Port-wine birthmark
 Not present 38 (14.2%)
 Unilateral 126 (47.0%)
 Bilateral 104 (38.8%)
Glaucoma
 Not present 128 (47.8%)
 Unilateral 103 (38.4%)
 Bilateral 32 (11.9%)
 Unknown 5 (1.9%)
Using an antiseizure medication
 Yes 240 (89.6%)
 No 28 (10.4%)
Using aspirin
 Yes 120 (44.8%)
 No 148 (55.2%)

Abbreviation:

SWS = Sturge-Weber syndrome